Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept. (Q51450723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

adult-onset Still's disease

4 February 2020

main subject

1 reference

1 reference

macrophage activation syndrome

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Koji Ishii

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Mikako Iwakura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Misuzu Akamine

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Hajime Hamasaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Itomi Abe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Miwa Haranaka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Hiroshi Tatsukawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Hironobu Yoshimatsu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

14 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

137-141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis and management of adult onset Still's disease

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

Etanercept in the treatment of adult patients with Still's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

Prolonged remission in adult-onset Still's disease with etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

Macrophage activation syndrome in juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatolo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0477-9

10.3109/S10165-011-0477-9

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670967%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference